Your session is about to expire
← Back to Search
18F fluciclovine for Brain Tumor (REVELATE Trial)
REVELATE Trial Summary
This trial is testing how well a new imaging technique can detect cancer that has come back in the brain after radiation therapy.
- Metastatic Brain Tumors
REVELATE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowREVELATE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 2 trial • 23 Patients • NCT04410367REVELATE Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What sort of health risks does 18F fluciclovine pose?
"Fluciclovine's safety is supported by prior Phase 3 trial data, so it received a score of 3."
Are new patients being accepted into this clinical trial right now?
"The clinical trial mentioned is no longer recruiting patients, as the last update on the website was from 422 days ago. However, there are 952 other trials that are actively recruiting patients."
Do we have any previous data to go on for this kind of treatment?
"7 clinical trials for 18F fluciclovine are currently underway in 21 cities and 1 country. The first study was completed in 2019 and it reached Phase 2 of drug approval. That initial study had 140 participants and was sponsored by Telix International Pty Ltd. In the 2 years since 2019, 5 more trials have been completed."
Does 18F fluciclovine have a long history of research?
"The year 2019 saw the first study of 18F fluciclovine at Emory Saint Joseph's Hospital. As of now, there have been 5 completed clinical trials. Additionally, there are 7 clinical trials underway, many of which are based in Houston, Texas."
How many people are allowed to sign up for this experiment?
"Unfortunately, this particular clinical trial is no longer recruiting patients. Originally posted on October 26th 2020, this study was last updated on April 11th, 2022. However, there are still many other trials looking for participants. There are 945 clinical trials actively seeking patients with neoplasm metastasis and 7 trials for 18F fluciclovine that are still looking for candidates."
In how many different settings is this research being conducted?
"To minimize participant burden, the trial's 19 sites are located in major cities including Houston, Salt Lake City, and Cleveland. Travel should not be a significant issue for prospective participants."
Share this study with friends
Copy Link
Messenger